Synovus Financial’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-273
| Closed | -$2.9K | – | 869 |
|
|
2023
Q4 | $2.9K | Hold |
273
| – | – | ﹤0.01% | 821 |
|
|
2023
Q3 | $5.4K | Hold |
273
| – | – | ﹤0.01% | 836 |
|
|
2023
Q2 | $20.9K | Sell |
273
-5
| -2% | -$383 | ﹤0.01% | 835 |
|
|
2023
Q1 | $26.3K | Hold |
278
| – | – | ﹤0.01% | 819 |
|
|
2022
Q4 | $27.1K | Buy |
278
+6
| +2% | +$585 | ﹤0.01% | 852 |
|
|
2022
Q3 | $70K | Buy |
272
+52
| +24% | +$13.4K | ﹤0.01% | 830 |
|
|
2022
Q2 | $41K | Sell |
220
-253
| -53% | -$47.2K | ﹤0.01% | 834 |
|
|
2022
Q1 | $46K | Buy |
473
+21
| +5% | +$2.04K | ﹤0.01% | 837 |
|
|
2021
Q4 | $74K | Hold |
452
| – | – | ﹤0.01% | 848 |
|
|
2021
Q3 | $124K | Buy |
452
+267
| +144% | +$73.2K | ﹤0.01% | 824 |
|
|
2021
Q2 | $73K | Hold |
185
| – | – | ﹤0.01% | 828 |
|
|
2021
Q1 | $100K | Hold |
185
| – | – | ﹤0.01% | 739 |
|
|
2020
Q4 | $70K | Hold |
185
| – | – | ﹤0.01% | 752 |
|
|
2020
Q3 | $70K | Buy |
+185
| New | +$70K | ﹤0.01% | 695 |
|
|
2018
Q2 | – | Sell |
-16
| Closed | -$9K | – | 1283 |
|
|
2018
Q1 | $9K | Buy |
+16
| New | +$9K | ﹤0.01% | 1053 |
|
|
2017
Q2 | – | Sell |
-16
| Closed | -$15K | – | 1074 |
|
|
2017
Q1 | $15K | Hold |
16
| – | – | ﹤0.01% | 905 |
|
|
2016
Q4 | $13K | Buy |
+16
| New | +$13K | ﹤0.01% | 897 |
|